• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

均质化技术在药物递送系统中的近期专利及潜在应用

Recent Patents and Potential Applications of Homogenisation Techniques in Drug Delivery Systems.

作者信息

Khanuja Harpreet Kaur, Dureja Harish

机构信息

Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak-124001, India.

出版信息

Recent Pat Nanotechnol. 2023;17(1):33-50. doi: 10.2174/1872210515666210719120203.

DOI:10.2174/1872210515666210719120203
PMID:34825646
Abstract

BACKGROUND

The term homogenise means "to force or provide coalesce". Homogenisation is a process to attain homogenous particle size. The objective of the homogenisation process is to use fluid force to split the fragments or tiny particles contained in the fluids into very small dimensions and form a sustainable dispersion suitable for further production.

METHODS

The databases were collected through Scopus, google patent, science web, google scholar, PubMed on the concept of homogenisation. The data obtained were systematically investigated.

RESULTS

The present study focus on the use of the homogenisation in drug delivery system. The aim of homogenisation process is to achieve the particle size in micro-and nano- range as it affects the different parameters in the formulation and biopharmaceutical profile of the drug. The particle size reduction plays a key role in influencing drug dissolution and absorption. The reduced particle size enhances the stability and therapeutic efficacy of the drug. Homogenization technology ensures to achieve effective, clinically efficient and targeted drug delivery with the minimal side effect.

CONCLUSION

Homogenization technology has been shown to be an efficient and easy method of size reduction to increase solubility and bioavailability, stability of drug carriers. This article gives an overview of the process attributes affecting the homogenization process, the patenting of homogeniser types, design, the geometry of valves and nozzles and its role in drug delivery.

摘要

背景

“均质化”一词意为“促使或使聚结”。均质化是一种实现均匀粒度的过程。均质化过程的目的是利用流体作用力将流体中所含的碎片或微小颗粒分裂成非常小的尺寸,并形成适合进一步生产的可持续分散体。

方法

通过Scopus、谷歌专利、科学网、谷歌学术、PubMed收集有关均质化概念的数据库。对获得的数据进行系统研究。

结果

本研究聚焦于均质化在药物递送系统中的应用。均质化过程的目的是实现微米和纳米级的粒度,因为它会影响药物制剂和生物药剂学特征中的不同参数。粒度减小在影响药物溶解和吸收方面起着关键作用。减小后的粒度可提高药物的稳定性和治疗效果。均质化技术确保以最小的副作用实现有效、临床高效且靶向的药物递送。

结论

均质化技术已被证明是一种有效且简便的减小粒度的方法,可提高药物载体的溶解度、生物利用度和稳定性。本文概述了影响均质化过程的工艺属性、均质器类型的专利情况、设计、阀门和喷嘴的几何形状及其在药物递送中的作用。

相似文献

1
Recent Patents and Potential Applications of Homogenisation Techniques in Drug Delivery Systems.均质化技术在药物递送系统中的近期专利及潜在应用
Recent Pat Nanotechnol. 2023;17(1):33-50. doi: 10.2174/1872210515666210719120203.
2
Patenting of nanopharmaceuticals in drug delivery: no small issue.纳米药物在药物递送方面的专利问题:绝非小事。
Recent Pat Drug Deliv Formul. 2007;1(2):131-42. doi: 10.2174/187221107780831941.
3
Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design, and Single-Pass Intestinal Perfusion (SPIP) Studies.辛伐他汀自乳化药物递送系统:处方开发、采用Box-Behnken设计进行优化以及单通道肠道灌注(SPIP)研究
Recent Pat Drug Deliv Formul. 2018;12(3):199-211. doi: 10.2174/1872211312666181022150435.
4
Self emulsifying drug delivery system (SEDDS) for phytoconstituents: a review.植物成分的自乳化药物递送系统(SEDDS)综述
Curr Drug Deliv. 2015;12(2):244-53. doi: 10.2174/1567201811666141021142606.
5
A Conceptual Analysis of Solid Self-emulsifying Drug Delivery System and its Associate Patents for the Treatment of Cancer.固体自乳化药物传递系统及其治疗癌症相关专利的概念分析。
Recent Pat Nanotechnol. 2021;15(2):92-104. doi: 10.2174/1872210514666200909155516.
6
Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin.多孔载体在卡格列净固体自微乳化药物递送系统生物药学性能中的作用
Recent Pat Drug Deliv Formul. 2018;12(3):179-198. doi: 10.2174/1872211312666181008111354.
7
An Overview on Recent Patents and Technologies on Solid Dispersion.固体分散体的最新专利和技术概述。
Recent Pat Drug Deliv Formul. 2020;14(1):63-74. doi: 10.2174/1872211314666200117094406.
8
Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters.纳米混悬剂——最新专利、制备方法和评价参数的更新。
Recent Pat Nanotechnol. 2021;15(4):351-366. doi: 10.2174/1872210514666201224103010.
9
Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.制备高再分散性干型联苯二酚纳米混悬剂以提高其稳定性、溶解性能和口服生物利用度。
Chin J Nat Med. 2016 Oct;14(10):757-768. doi: 10.1016/S1875-5364(16)30090-5. Epub 2016 Oct 31.
10
Modified alginate beads for mucoadhesive drug delivery system: an updated review of patents.用于粘膜粘附给药系统的改性藻酸盐珠:专利最新综述
Recent Pat Drug Deliv Formul. 2012 Dec;6(3):259-77. doi: 10.2174/187221112802652697.

引用本文的文献

1
Beyond transplants: current and future therapeutic potential of amniotic membrane extract (AME) in ophthalmology.超越移植:羊膜提取物(AME)在眼科的当前及未来治疗潜力
Regen Med. 2025 Feb-Mar;20(2-3):97-109. doi: 10.1080/17460751.2025.2472578. Epub 2025 Mar 3.